Cited by 25Protein Kinase Regulation and GTPase SignalingCell Adhesion Molecules ResearchAngiogenesis and VEGF in Cancer

Expression of RAC2 in endothelial cells is required for the postnatal neovascular response

Open access
De, Pradip, Peng, Qiong, Traktuevc, Dmitry O., Li, Weiming, Yoder, Mervin C., March, Keith L., Durden, Donald L.·2009·Experimental Cell Research

Abstract

Herein, we describe an obligate role for the hematopoietic specific GTPase, RAC2 in endothelial integrin signaling and the postnatal neovascularization response in vivo. Using a Rac2 knockout mouse model, we discovered that despite the presence of both RAC1 and RAC2 protein in endothelial cells, RAC2 is obligately required for the postnatal neovascular response and alphavbeta3/ alpha4beta1/alpha5beta1 integrin-directed migration on vitronectin, H296 and CH271, fibronectin fragments, respectively. The molecular basis for RAC2 specificity was explored. A genetic analysis of Syk -/+ or Syk-/+;Rac2 -/+ mice revealed that SYK kinase is required for the integrin induced activation of RAC2. The analysis of endothelial cells from Rac2-/+ versus Syk-/+;Rac2-/+ mice provided genetic evidence that SYK-RAC2 signaling axis regulates integrin (alphavbeta3, alpha4beta1 and alpha5beta1) dependent migration. Our results provide evidence that a specific region of the nonreceptor protein tyrosine kinase, SYK, the B linker region containing Y342 and Y346 is required for SYK's regulation of RAC2 and integrin dependent migration. Moreover, the capacity of mice to vascularize the ischemic hindlimb following femoral artery ligation or matrigel plugs was markedly reduced in mice homozygous deficient for the Rac2 gene. These findings identify a novel signaling axis for the induction and potential modulation of postnatal angiogenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.yexcr.2008.10.003

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Rac2 knockout mice display a number of hematopoietic defects mostly in blood cell-specific receptor function or hematopoietic-specific effector mechanisms and in kinase pathway-activated cell survival.

    “the Rac2 knockout mice display a number of hematopoietic defects mostly in the context of blood cell-specific receptor function or hematopoietic-specific effector mechanisms and also in kinase pathway-activated cell survival [1], [2], [6], [7], [8].”

    From Rac2 Controls Tumor Growth, Metastasis and M1-M2 Macrophage Differentiation In Vivo (2014) · cites this paper as [1]

    The Introduction (page unavailable) reports neutrophil, macrophage, and mast-cell defects in Rac2 knockout mice. The Results discuss integrin-directed signaling and SYK-dependent RAC2 activation, but in endothelial cells; the cited paper does not establish kinase pathway-activated cell-survival defects in the knockout mice. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • In the absence of Rac2, macrophages and/or neutrophils display defective chemotaxis.

    “Previous findings clearly demonstrate that in the absence of Rac2, macrophages and/or neutrophils display suppressed reactive oxygen species (ROS) production, defective chemotaxis, impaired phagocytosis, and decreased microbial killing [1], [2], [6], [7], [8].”

    From Rac2 Controls Tumor Growth, Metastasis and M1-M2 Macrophage Differentiation In Vivo (2014) · cites this paper as [1]

    The Results section states that previous work found RAC2 necessary for macrophage integrin-directed migration. That supports a related migration defect, but integrin-directed migration is not the same as chemotaxis, and this paper does not report defective chemotaxis in RAC2-deficient macrophages or neutrophils. No page number is available in our copy. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • α4β1/αvβ3-induced migration requires Rac2 in macrophages and endothelial cells, and this pathway regulates the postnatal angiogenic response in vivo.

    “The current investigation began with our initial observation that the provisional integrins, α4β1/αvβ3 induced migration requires a specific isoform of Rac, Rac2 in macrophages and endothelial cells and that this pathway regulated the postnatal angiogenic response in vivo [1], [2].”
  • In the absence of Rac2, macrophages and/or neutrophils display decreased microbial killing.

    “Previous findings clearly demonstrate that in the absence of Rac2, macrophages and/or neutrophils display suppressed reactive oxygen species (ROS) production, defective chemotaxis, impaired phagocytosis, and decreased microbial killing [1], [2], [6], [7], [8].”

    From Rac2 Controls Tumor Growth, Metastasis and M1-M2 Macrophage Differentiation In Vivo (2014) · cites this paper as [1]

    The Results section discusses RAC2-dependent macrophage migration, while the References list a study of neutrophil function and host defense. Neither passage states that Rac2-deficient macrophages or neutrophils have decreased microbial killing. Searches for microbial killing, killing, and infection found no passage addressing that outcome. (LLM, conf=0.72)

    Experimental — accuracy not yet measured
  • In the absence of Rac2, macrophages and/or neutrophils display suppressed reactive oxygen species (ROS) production.

    “Previous findings clearly demonstrate that in the absence of Rac2, macrophages and/or neutrophils display suppressed reactive oxygen species (ROS) production, defective chemotaxis, impaired phagocytosis, and decreased microbial killing [1], [2], [6], [7], [8].”

    From Rac2 Controls Tumor Growth, Metastasis and M1-M2 Macrophage Differentiation In Vivo (2014) · cites this paper as [1]

    The Results discuss RAC2-dependent macrophage migration, while the paper’s experiments concern endothelial migration and neovascularization. A References entry names a study of RAC2 and neutrophil NADPH oxidase activation, but no passage in our copy reports suppressed ROS production in RAC2-deficient macrophages or neutrophils (searched: ROS, reactive oxygen species, oxidative burst, and NADPH oxidase). (LLM, conf=0.72)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 55

  1. [1]Risau W 1997 Mechanisms of angiogenesis Nature 386 671 4 9109485
  2. [2]Folkman J Watson K Ingber D Hanahan D 1989 Induction of angiogenesis during the transition from hyperplasia to neoplasia Nature 339 58 61 2469964
  3. [3]Benezra R Rafii S Lyden D 2001 The Id proteins and angiogenesis Oncogene 20 8334 41 11840326
  4. [4]Jin DK Shido K Kopp HG Petit I Shmelkov SV Young LM Hooper AT Amano H Avecilla ST Heissig B Hattori K Zhang F Hicklin DJ Wu Y Zhu Z Dunn A Salari H Werb Z Hackett NR Crystal RG Lyden D Rafii S 2006 Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes Nat Med 12 557 67 16648859 PMC2754288
  5. [5]Zengin E Chalajour F Gehling UM Ito WD Treede H Lauke H Weil J Reichenspurner H Kilic N Ergun S 2006 Vascular wall resident progenitor cells: a source for postnatal vasculogenesis Development 133 1543 51 16524930
  6. [6]Avraamides CJ Garmy-Susini B Varner JA 2008 Integrins in angiogenesis and lymphangiogenesis Nat Rev Cancer 8 604 17 18497750 PMC2577722
  7. [7]Bryan BA D’Amore PA 2007 What tangled webs they weave: Rho-GTPase control of angiogenesis Cell Mol Life Sci 64 2053 65 17530172 PMC11138424
  8. [8]Van Aelst L D’Souza-Schorey C 1997 Rho GTPases and signaling networks Genes Dev 11 2295 322 9308960
  9. [9]Didsbury J Weber RF Bokoch GM Evans T Snyderman R 1989 rac, a novel ras-related family of proteins that are botulinum toxin substrates J Biol Chem 264 16378 82 2674130
  10. [10]Quinn MT Evans T Loetterle LR Jesaitis AJ Bokoch GM 1993 Translocation of Rac correlates with NADPH oxidase activation. Evidence for equimolar translocation of oxidase components J Biol Chem 268 20983 7 8407934
  11. [11]Roberts AW Kim C Zhen L Lowe JB Kapur R Petryniak B Spaetti A Pollock JD Borneo JB Bradford GB Atkinson SJ Dinauer MC Williams DA 1999 Deficiency of the hematopoietic cell-specific Rho family GTPase Rac2 is characterized by abnormalities in neutrophil function and host defense Immunity 10 183 96 10072071
  12. [12]Pradip D Peng X Durden DL 2003 Rac2 specificity in macrophage integrin signaling: potential role for Syk kinase J Biol Chem 278 41661 9 12917394
  13. [13]Kim C Dinauer MC 2001 Rac2 is an essential regulator of neutrophil nicotinamide adenine dinucleotide phosphate oxidase activation in response to specific signaling pathways J Immunol 166 1223 32 11145705
  14. [14]Podsypanina K Ellenson LH Nemes A Gu J Tamura M Yamada KM Cordon-Cardo C Catoretti G Fisher PE Parsons R 1999 Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems Proc Natl Acad Sci U S A 96 1563 8 9990064 PMC15517
  15. [15]Mocsai A Zhou M Meng F Tybulewicz VL Lowell CA 2002 Syk is required for integrin signaling in neutrophils Immunity 16 547 58 11970878
  16. [16]Erdreich-Epstein A Shimada H Groshen S Liu M Metelitsa LS Kim KS Stins MF Seeger RC Durden DL 2000 Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide Cancer Res 60 712 21 10676658
  17. [17]Yatohgo T Izumi M Kashiwagi H Hayashi M 1988 Novel purification of vitronectin from human plasma by heparin affinity chromatography Cell Struct Funct 13 281 92 2460263
  18. [18]Motoike T Loughna S Perens E Roman BL Liao W Chau TC Richardson CD Kawate T Kuno J Weinstein BM Stainier DY Sato TN 2000 Universal GFP reporter for the study of vascular development Genesis 28 75 81 11064424
  19. [19]Li W Johnson SA Shelley WC Ferkowicz M Morrison P Li Y Yoder MC 2003 Primary endothelial cells isolated from the yolk sac and para-aortic splanchnopleura support the expansion of adult marrow stem cells in vitro Blood 102 4345 53 12893772
  20. [20]Hinds MT Ma M Tran N Ensley AE Kladakis SM Vartanian KB Markway BD Nerem RM Hanson SR 2008 Potential of baboon endothelial progenitor cells for tissue engineered vascular grafts J Biomed Mater Res A 86 804 12 18041726
  21. [21]Klemke RL Cai S Giannini AL Gallagher PJ de Lanerolle P Cheresh DA 1997 Regulation of cell motility by mitogen-activated protein kinase J Cell Biol 137 481 92 9128257 PMC2139771
  22. [22]Nicosia RF Ottinetti A 1990 Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro Lab Invest 63 115 22 1695694
  23. [23]Couffinhal T Silver M Zheng LP Kearney M Witzenbichler B Isner JM 1998 Mouse model of angiogenesis Am J Pathol 152 1667 79 9626071 PMC1858441
  24. [24]Rivard A Fabre JE Silver M Chen D Murohara T Kearney M Magner M Asahara T Isner JM 1999 Age-dependent impairment of angiogenesis Circulation 99 111 20 9884387
  25. [25]Zanetta L Marcus SG Vasile J Dobryansky M Cohen H Eng K Shamamian P Mignatti P 2000 Expression of Von Willebrand factor, an endothelial cell marker, is up-regulated by angiogenesis factors: a potential method for objective assessment of tumor angiogenesis Int J Cancer 85 281 8 10629090
  26. [26]Burger PE Coetzee S McKeehan WL Kan M Cook P Fan Y Suda T Hebbel RP Novitzky N Muller WA Wilson EL 2002 Fibroblast growth factor receptor-1 is expressed by endothelial progenitor cells Blood 100 3527 35 12411316
  27. [28]Yanagi S Inatome R Ding J Kitaguchi H Tybulewicz VL Yamamura H 2001 Syk expression in endothelial cells and their morphologic defects in embryonic Syk-deficient mice Blood 98 2869 71 11675365
  28. [29]Yanagi S Inatome R Takano T Yamamura H 2001 Syk expression and novel function in a wide variety of tissues Biochem Biophys Res Commun 288 495 8 11676469
  29. [30]Friedlander M Brooks PC Shaffer RW Kincaid CM Varner JA Cheresh DA 1995 Definition of two angiogenic pathways by distinct alpha v integrins Science 270 1500 2 7491498
  30. [31]Reynolds LE Wyder L Lively JC Taverna D Robinson SD Huang X Sheppard D Hynes RO Hodivala-Dilke KM 2002 Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins Nat Med 8 27 34 11786903
  31. [32]Cheresh DA Stupack DG 2002 Integrin-mediated death: an explanation of the integrin-knockout phenotype? Nat Med 8 193 4 11875466
  32. [33]Turner M Mee PJ Costello PS Williams O Price AA Duddy LP Furlong MT Geahlen RL Tybulewicz VL 1995 Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk Nature 378 298 302 7477352
  33. [34]Lyden D Hattori K Dias S Costa C Blaikie P Butros L Chadburn A Heissig B Marks W Witte L Wu Y Hicklin D Zhu Z Hackett NR Crystal RG Moore MA Hajjar KA Manova K Benezra R Rafii S 2001 Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth Nat Med 7 1194 201 11689883
  34. [35]Brooks PC Clark RA Cheresh DA 1994 Requirement of vascular integrin alpha v beta 3 for angiogenesis Science 264 569 71 7512751
  35. [36]Gory-Faure S Prandini MH Pointu H Roullot V Pignot-Paintrand I Vernet M Huber P 1999 Role of vascular endothelial-cadherin in vascular morphogenesis Development 126 2093 102 10207135
  36. [37]Breier G Breviario F Caveda L Berthier R Schnurch H Gotsch U Vestweber D Risau W Dejana E 1996 Molecular cloning and expression of murine vascular endothelial-cadherin in early stage development of cardiovascular system Blood 87 630 41 8555485
  37. [38]Gale NW Yancopoulos GD 1999 Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development Genes Dev 13 1055 66 10323857
  38. [39]Hanahan D 1997 Signaling vascular morphogenesis and maintenance Science 277 48 50 9229772
  39. [40]Koretzky GA Abtahian F Derimanov GS Dmowski SA Guerriero A Jordan MS Maltzman JS Olenchock BA Singer AL Wu JN Zhong XP 2003 Regulation of hematopoietic cell development and activation by adapter proteins Immunol Res 27 357 66 12857981
  40. [41]Sebzda E Hibbard C Sweeney S Abtahian F Bezman N Clemens G Maltzman JS Cheng L Liu F Turner M Tybulewicz V Koretzky GA Kahn ML 2006 Syk and Slp-76 mutant mice reveal a cell-autonomous hematopoietic cell contribution to vascular development Dev Cell 11 349 61 16950126
  41. [42]Deckert M Tartare-Deckert S Couture C Mustelin T Altman A 1996 Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product Immunity 5 591 604 8986718
  42. [43]Piccolo E Innominato PF Mariggio MA Maffucci T Iacobelli S Falasca M 2002 The mechanism involved in the regulation of phospholipase Cgamma1 activity in cell migration Oncogene 21 6520 9 12226755
  43. [44]Gevrey JC Isaac BM Cox D 2005 Syk is required for monocyte/macrophage chemotaxis to CX3CL1 (Fractalkine) J Immunol 175 3737 45 16148119
  44. [45]Braga VM Betson M Li X Lamarche-Vane N 2000 Activation of the small GTPase Rac is sufficient to disrupt cadherin-dependent cell-cell adhesion in normal human keratinocytes Mol Biol Cell 11 3703 21 11071901 PMC15031
  45. [46]Fernandez-Zapico ME Gonzalez-Paz NC Weiss E Savoy DN Molina JR Fonseca R Smyrk TC Chari ST Urrutia R Billadeau DD 2005 Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis Cancer Cell 7 39 49 15652748
  46. [47]Mira JP Benard V Groffen J Sanders LC Knaus UG 2000 Endogenous, hyperactive Rac3 controls proliferation of breast cancer cells by a p21-activated kinase-dependent pathway Proc Natl Acad Sci U S A 97 185 9 10618392 PMC26637
  47. [48]Sahai E Marshall CJ 2002 RHO-GTPases and cancer Nat Rev Cancer 2 133 42 12635176
  48. [49]Ming W Li S Billadeau DD Quilliam LA Dinauer MC 2007 The Rac effector p67phox regulates phagocyte NADPH oxidase by stimulating Vav1 guanine nucleotide exchange activity Mol Cell Biol 27 312 23 17060455 PMC1800642
  49. [50]Groesch TD Zhou F Mattila S Geahlen RL Post CB 2006 Structural basis for the requirement of two phosphotyrosine residues in signaling mediated by Syk tyrosine kinase J Mol Biol 356 1222 36 16410013
  50. [51]Jacinto E Werlen G Karin M 1998 Cooperation between Syk and Rac1 leads to synergistic JNK activation in T lymphocytes Immunity 8 31 41 9462509
  51. [52]Carmeliet P Ferreira V Breier G Pollefeyt S Kieckens L Gertsenstein M Fahrig M Vandenhoeck A Harpal K Eberhardt C Declercq C Pawling J Moons L Collen D Risau W Nagy A 1996 Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele Nature 380 435 9 8602241
  52. [53]Mahabeleshwar GH Feng W Phillips DR Byzova TV 2006 Integrin signaling is critical for pathological angiogenesis J Exp Med 203 2495 507 17030947 PMC2118124
  53. [54]Cowan KJ Law DA Phillips DR 2000 Identification of shc as the primary protein binding to the tyrosine-phosphorylated beta 3 subunit of alpha IIbbeta 3 during outside-in integrin platelet signaling J Biol Chem 275 36423 9 10964917
  54. [55]Ingram DA Mead LE Moore DB Woodard W Fenoglio A Yoder MC 2005 Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells Blood 105 2783 6 15585655
  55. [56]Ingram DA Mead LE Tanaka H Meade V Fenoglio A Mortell K Pollok K Ferkowicz MJ Gilley D Yoder MC 2004 Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood Blood 104 2752 60 15226175

Cited by

Sorted by citations

Authors
De, P., Peng, Q., Traktuevc, D. O., Li, W., Yoder, M. C., March, K. L., & Durden, D. L.
Affiliations
  • Emory University (US)
  • Indiana University Indianapolis (US)
Corresponding author
Durden, Donald L.
Venue
Experimental Cell Research
Publisher
Elsevier BV
Published
2009-01
Volume
315
Issue
2
Pages
248-263
ISSN
0014-4827 (ISSN-L)
OpenAlex
W1965784559
Cited by
25
References
1
Citations by year
2025: 1 · 2023: 2 · 2022: 3 · 2021: 1 · 2020: 2 · 2019: 3 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 3 · 2013: 4
FWCI
0.14
Type
journal article
Language
en
Update notices
erratum (2009-10-01)
Open access
Locations
  • Experimental Cell Research (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • IUScholarWorks (Indiana University) (submittedVersion)
Funders
  • Georgia Cancer Coalition
  • Emory University
  • National Institutes of Health (R56CA94233)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
Rac2, endothelial cells, angiogenesis, integrin signaling, Syk, Rac1, integrin αvβ3, alpha4beta1 integrin, alpha5beta1 integrin, cell migration, vitronectin, fibronectin fragments, hindlimb ischemia
MeSH terms
Syk Kinase, RAC2 GTP-Binding Protein, Animals, Cell Movement, Chlorocebus aethiops, Fibronectins, Hindlimb, Humans, Mice, Inbred C57BL, Neuropeptides, Papio, Protein-Tyrosine Kinases, Regional Blood Flow, Signal Transduction, Reperfusion Injury, Gene Expression, Mice, Knockout, Neovascularization, Physiologic, Vitronectin, COS Cells, rac GTP-Binding Proteins, rac1 GTP-Binding Protein, RNA, Small Interfering, Integrin alpha4beta1, Integrin alphaVbeta3, Endothelial Cells, Intracellular Signaling Peptides and Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review